Multiple myeloma survival down with high ADAR1 RNA expression

(HealthDay)—Amplification of the inflammation-responsive RNA editase adenosine deaminase acting on RNA (ADAR)1 gene is associated with reduced survival in multiple myeloma (MM), according to a study p

Updated on: March 30,2024

Multiple myeloma survival down with high ADAR1 RNA expression

(HealthDay)—Amplification of the inflammation-responsive RNA editase adenosine deaminase acting on RNA (ADAR)1 gene is associated with reduced survival in multiple myeloma (MM), according to a study p

Updated on:March 30,2024

Discovering cancers of epigenetic origin without DNA mutation

byCNRSExample of a tumor obtained by reducing the expression levels of a Polycomb protein. On the left is an example of precursor tissue of the eye during normal development. On the right, a tum

Updated on: April 28,2024

Discovering cancers of epigenetic origin without DNA mutation

byCNRSExample of a tumor obtained by reducing the expression levels of a Polycomb protein. On the left is an example of precursor tissue of the eye during normal development. On the right, a tum

Updated on:April 28,2024

Peripheral surrogates of tumor burden to guide therapeutic strategies for HPV-associated malignancies

by Impact Journals LLCTumor intrinsic and extrinsic factors in the periphery that can serve as proxies of tumor burden. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28487A new review

Updated on: January 22,2024

Peripheral surrogates of tumor burden to guide therapeutic strategies for HPV-associated malignancies

by Impact Journals LLCTumor intrinsic and extrinsic factors in the periphery that can serve as proxies of tumor burden. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28487A new review

Updated on:January 22,2024

Study finds worsening metabolic syndrome increases the risk of developing cancer

by WileyCredit: Pavel Danilyuk from PexelsNew research indicates that individuals with persistent and worsening metabolic syndrome—which encompasses conditions such as high blood pressure, elevat

Updated on: March 20,2024

Study finds worsening metabolic syndrome increases the risk of developing cancer

by WileyCredit: Pavel Danilyuk from PexelsNew research indicates that individuals with persistent and worsening metabolic syndrome—which encompasses conditions such as high blood pressure, elevat

Updated on:March 20,2024

Living close to urban green spaces is associated with decreased breast cancer risk

by Barcelona Institute for Global Health (ISGlobal)Credit: CC0 Public DomainAn increasing number of studies are reporting the health benefits of contact with urban green spaces. A new study from the B

Updated on: April 07,2024

Living close to urban green spaces is associated with decreased breast cancer risk

by Barcelona Institute for Global Health (ISGlobal)Credit: CC0 Public DomainAn increasing number of studies are reporting the health benefits of contact with urban green spaces. A new study from the B

Updated on:April 07,2024

Targeting refractory prostate cancer: A novel radiopharmaceutical hits the bullseye

by Osaka UniversityTargeted alpha therapy using an astatine-labeled PSMA ligand ([At-211]PSMA5). Credit: Tadashi Watabe (Osaka University)As the saying goes, when all you have is a hammer, everyt

Updated on: February 23,2024

Targeting refractory prostate cancer: A novel radiopharmaceutical hits the bullseye

by Osaka UniversityTargeted alpha therapy using an astatine-labeled PSMA ligand ([At-211]PSMA5). Credit: Tadashi Watabe (Osaka University)As the saying goes, when all you have is a hammer, everyt

Updated on:February 23,2024

Startup to commercialize blood test for most major cancers

by Paul Tumarkin,University of ArizonaCredit: University of ArizonaWhen testing for such as lung cancer disease, doctors know that tissue biopsies are necessary and potentially life-saving, thou

Updated on: April 14,2024

Startup to commercialize blood test for most major cancers

by Paul Tumarkin,University of ArizonaCredit: University of ArizonaWhen testing for such as lung cancer disease, doctors know that tissue biopsies are necessary and potentially life-saving, thou

Updated on:April 14,2024

Fred Hutch researchers engineer complex immunotherapy that may target relapsing leukemia

by Fred Hutchinson Cancer Research CenterDr. Marie Bleakley, a pediatric oncologist and researcher at Fred Hutch, is advancing a new approach to genetically engineer T cells. Credit: Fred HutchOc

Updated on: March 06,2024

Fred Hutch researchers engineer complex immunotherapy that may target relapsing leukemia

by Fred Hutchinson Cancer Research CenterDr. Marie Bleakley, a pediatric oncologist and researcher at Fred Hutch, is advancing a new approach to genetically engineer T cells. Credit: Fred HutchOc

Updated on:March 06,2024

Stress-tolerant cells shown to drive tumor initiation in pancreatic cancer

by University of California - San DiegoTumor-initiating cells (blue) produce an extracellular matrix containing fibronectin (pink) which gives them increased stress tolerance, drug resistance and

Updated on: February 23,2024

Stress-tolerant cells shown to drive tumor initiation in pancreatic cancer

by University of California - San DiegoTumor-initiating cells (blue) produce an extracellular matrix containing fibronectin (pink) which gives them increased stress tolerance, drug resistance and

Updated on:February 23,2024

The blind use of AI in health care can lead to invisible discrimination

by University of CopenhagenCredit: CC0 Public DomainArtificial intelligence can help health care systems under pressure allocate limited resources, but also lead to more unequal access. This is d

Updated on: April 22,2024

The blind use of AI in health care can lead to invisible discrimination

by University of CopenhagenCredit: CC0 Public DomainArtificial intelligence can help health care systems under pressure allocate limited resources, but also lead to more unequal access. This is d

Updated on:April 22,2024

Survival similar for Black, White prostate cancer patients in clinical trial setting

by Elana GotkineFor metastatic castration-sensitive prostate cancer (mCSPC), overall survival and progression-free survival are similar for Black and White patients receiving first- or second-generati

Updated on: February 03,2024

Survival similar for Black, White prostate cancer patients in clinical trial setting

by Elana GotkineFor metastatic castration-sensitive prostate cancer (mCSPC), overall survival and progression-free survival are similar for Black and White patients receiving first- or second-generati

Updated on:February 03,2024

Researchers complete largest genomic analysis of Merkel cell carcinoma patients

by H. Lee Moffitt Cancer Center & Research InstituteCredit: CC0 Public DomainMerkel cell carcinoma (MCC) is a rare, aggressive skin tumor that is diagnosed in approximately 2,000 people each

Updated on: June 04,2024

Researchers complete largest genomic analysis of Merkel cell carcinoma patients

by H. Lee Moffitt Cancer Center & Research InstituteCredit: CC0 Public DomainMerkel cell carcinoma (MCC) is a rare, aggressive skin tumor that is diagnosed in approximately 2,000 people each

Updated on:June 04,2024